197 related articles for article (PubMed ID: 33684562)
1. Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
Court R; Centner CM; Chirehwa M; Wiesner L; Denti P; de Vries N; Harding J; Gumbo T; Maartens G; McIlleron H
Int J Infect Dis; 2021 Apr; 105():688-694. PubMed ID: 33684562
[TBL] [Abstract][Full Text] [Related]
2. Steady-state population pharmacokinetics of terizidone and its metabolite cycloserine in patients with drug-resistant tuberculosis.
Mulubwa M; Mugabo P
Br J Clin Pharmacol; 2019 Sep; 85(9):1946-1956. PubMed ID: 31046167
[TBL] [Abstract][Full Text] [Related]
3. [Rezonizat and cycloserine in complex therapy of drug resistant tuberculosis (comparative studies)].
Sokolova GB; Lazareva IaR; Kirtaeva OV; Romanova EV; Tsybane AA
Antibiot Khimioter; 2008; 53(11-12):25-8. PubMed ID: 19441654
[TBL] [Abstract][Full Text] [Related]
4. Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
Court R; Wiesner L; Stewart A; de Vries N; Harding J; Maartens G; Gumbo T; McIlleron H
Int J Tuberc Lung Dis; 2018 Jan; 22(1):30-33. PubMed ID: 29297422
[TBL] [Abstract][Full Text] [Related]
5. Safety of cycloserine and terizidone for the treatment of drug-resistant tuberculosis: a meta-analysis.
Hwang TJ; Wares DF; Jafarov A; Jakubowiak W; Nunn P; Keshavjee S
Int J Tuberc Lung Dis; 2013 Oct; 17(10):1257-66. PubMed ID: 23735593
[TBL] [Abstract][Full Text] [Related]
6. Treatment Outcomes and Adverse Drug Effects of Ethambutol, Cycloserine, and Terizidone for the Treatment of Multidrug-Resistant Tuberculosis in South Africa.
van der Walt ML; Shean K; Becker P; Keddy KH; Lancaster J
Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046491
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone.
Chirehwa MT; Court R; de Kock M; Wiesner L; de Vries N; Harding J; Gumbo T; Maartens G; Warren R; Denti P; McIlleron H
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816738
[TBL] [Abstract][Full Text] [Related]
8. Psychiatric issues in the management of patients with multidrug-resistant tuberculosis.
Vega P; Sweetland A; Acha J; Castillo H; Guerra D; Smith Fawzi MC; Shin S
Int J Tuberc Lung Dis; 2004 Jun; 8(6):749-59. PubMed ID: 15182146
[TBL] [Abstract][Full Text] [Related]
9. Serious treatment related adverse drug reactions amongst anti-retroviral naïve MDR-TB patients.
Van der Walt M; Lancaster J; Odendaal R; Davis JG; Shean K; Farley J
PLoS One; 2013; 8(4):e58817. PubMed ID: 23573193
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic Modeling, Simulation, and Development of a Limited Sampling Strategy of Cycloserine in Patients with Multidrug-/Extensively Drug-Resistant Tuberculosis.
van der Galiën R; Boveneind-Vrubleuskaya NV; Peloquin C; Skrahina A; Touw DJ; Alffenaar JC
Clin Pharmacokinet; 2020 Jul; 59(7):899-910. PubMed ID: 31981103
[TBL] [Abstract][Full Text] [Related]
11. Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis.
Mulubwa M; Mugabo P
Drugs R D; 2019 Sep; 19(3):289-296. PubMed ID: 31396892
[TBL] [Abstract][Full Text] [Related]
12. Cycloserine induced psychosis with hepatic dysfunction.
Tandon VR; Rani N; Roshi ; Gupta R; Arora M; Khajuria V; Mahajan V
Indian J Pharmacol; 2015; 47(2):230-1. PubMed ID: 25878391
[TBL] [Abstract][Full Text] [Related]
13. Cycloserine-induced psychosis in a young female with drug-resistant tuberculosis.
Sharma B; Handa R; Nagpal K; Prakash S; Gupta PK; Agrawal R
Gen Hosp Psychiatry; 2014; 36(4):451.e3-4. PubMed ID: 24766906
[TBL] [Abstract][Full Text] [Related]
14. Optimizing dosing of the cycloserine pro-drug terizidone in children with rifampicin-resistant tuberculosis.
van der Laan LE; Garcia-Prats AJ; McIlleron H; Abdelwahab MT; Winckler JL; Draper HR; Wiesner L; Schaaf HS; Hesseling AC; Denti P
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0061123. PubMed ID: 37971239
[TBL] [Abstract][Full Text] [Related]
15. [Russian cycloserine in complex therapy of drug resistant tuberculosis].
Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA
Antibiot Khimioter; 2008; 53(5-6):32-4. PubMed ID: 19069180
[No Abstract] [Full Text] [Related]
16. Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us.
Intini E; Kishore G; Richeldi L; Udwadia ZF
BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31806629
[TBL] [Abstract][Full Text] [Related]
17. A patient of multidrug-resistant tuberculosis on category IV treatment regimen presenting with psychosis.
Sarkar S; Sood M
Natl Med J India; 2011; 24(4):244-5. PubMed ID: 22208150
[No Abstract] [Full Text] [Related]
18. Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB.
Conradie F; Mabiletsa T; Sefoka M; Mabaso S; Louw R; Evans D; Van Rie A
S Afr Med J; 2013 Oct; 104(1):24-6. PubMed ID: 24388081
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome in cycloserine-induced psychosis.
Sawant NS; Kate NS; Bhatankar SS; Kulkarni PS
Indian J Pharmacol; 2015; 47(3):328-9. PubMed ID: 26069374
[TBL] [Abstract][Full Text] [Related]
20. [A case of multi-drug resistant tuberculosis showing psychiatric adverse effect by cycloserine].
Fujita J; Sunada K; Hayashi H; Hayashihara K; Saito T
Kekkaku; 2008 Jan; 83(1):21-5. PubMed ID: 18283911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
